-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q4 2024.
- Hepion Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 123K shares, a 54.7% increase year-over-year.
- Hepion Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 123K shares, a 54.7% increase from 2023.
- Hepion Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 79.4K shares, a 97.9% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.81M shares, a 94.6% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)